ResearchThe Department of Pharmacy Practice has active research programs in the pharmacotherapy of disease as well as the practice of pharmacy. Areas of focus within the department include infectious diseases, cardiovascular therapy, diabetes, pediatrics, osteoporosis, anticoagulation, neuropharmacology and pain management. In addition, several faculty members are engaged in research related to alternative practice models for pharmacists in the community.
For more faculty publications, browse the department database. |
|
Recent Publications(Click on any research publication below to find out more.)Kerns R, Rybak MJ. Susceptibility studies of piperazinyl-crosslinked fluoroquinolone dimers against test strains of Gram-positive and Gram-negative bacteria. Diagnostic Microbiology and Infectious Disease. 2005; 229R1 Anand KJ, Aranda JV Berde CB, Buckman S, Capparelli EV, Carlo WA, Hummel P, Lantos J, Johnston CC, Lehr VT, et al.. Analgesia and anesthesia for neonates: study design and ethical issues. Clin Ther. 2005; 27: 814-43 Anand KJ, Johnston CC, Oberlander TF, Taddio A, Lehr VT, Walco GA. Analgesia and local anesthesia during invasive procedures in the neonate. Clin Ther. 2005; 27: 844-76 Aranda JV, Carlo W, Hummel P, Thomas R, Lehr VT, Anand KJ. Analgesia and sedation during mechanical ventilation in neonates. Clin Ther. 2005; 27: 877-899 Beringer PM, Slaughter RL. Transporters and their impact on drug disposition. Annals of Pharmacotherapy. 2005; 39: 1097-1108 DeRyke CA, Lodise TP, Rybak MJ, McKinnon PS. Epidemiology, treatment and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest. 2005; 128: 1414-1422 Foster DR, Rhoney DH. Enterobacter meningitis: organism susceptibilities, antimicrobial therapy and related outcomes. Surg Neurol. 2005; 63: 533-537 Huang V, Rybak MJ. Evaluation of daptomycin activity against Staphylococcus aureus in an in vitro pharmacodynamic model under normal and simulated impaired renal function. Journal of Antimicrobial Chemotherapy. 2005; Tsuji BT, Rybak MJ. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegtetations. Antimicrobial Agents and Chemotherapy. 2005; 49: 2735-2745 O'Connell MB, Madden DM, Muarray AM, Heaney RP, Kerzner LB. Effect of proton pump inhibition on 45-calcium carbonate absorption: A randomized double blind, placebo-controlled, crossover clinical trial. American Journal of Medicine. 2005; 118: 778-781 Linnebur SA, O'Connell MB, Wessell AM, McCord A, Kennedy DH, Demaagd G, Dent LA, Splinter MY, Biery JC, Chang F, Jackson RC, Miller SL, Sterling T, for the 2004 ACCP Task Force on Pharmacy and the Elderly. Pharmacy practice, research, education and advocacy for older adults. Pharmacotherapy. 2005; 25: 1396-1430 Smythe MA, Stephens JL, Koerber JM, Mattson JC. A comparison of lepirduin and argatroban outcomes. Clin Appl Hemost Thromb. 2005; 11: 371-374 Stephens JL, Koerber JM, Mattson JC, Smythe MA. The effect of lepirudin on the international normalized ratio. Annals of Pharmacotherapy. 2005; 39: 28-31 Smythe MA, Stephens JL, Mattson JC. Delayed onset heparin induced thromobcytopenia. Annals of Emergency Medicine. 2005; 4: 417-419 Spinler SA, Wittkowsky AK, Nutescu EA, Smythe MA. Point of care anticoagulation monitoring, Part 2: Unfractionated heparin and low molecular weight heparin. Annals of Pharmacotherapy. 2005; 39: 1275-85 Spinler SA, Nutescu EA, Smythe MA, Wittkowsky AK. Point of care anticoagulation monitoring, Part 1: Warfarin and parenteral direct thrombin inhibitors. Annals of Pharmacotherapy. 2005; 39: 1049-55 Tutag-Lehr V, Cepeda E, Frattarelli DAC, Thomas R, LaMothe J, Aranda JV. Lidocaine 4% cream (LMX4) compared with lidocaine 2.5%-prilocaine 2.5% (EMLA) or dorsal penile block for circumcision. American Journal of Perinatology. 2005; DOI:10.1055/s-2005-87152 Frattarelli DAC, Ergun H, Lulic-Botica M, Tutag-Lehr, Aranda JV. Vancomycin elimination in human infants with intrauterine growth retardation. Pediatric Infect Dis J. 2005; 24: 979-83 Kalus JS, White CM, Caron MF, Guertin D, McBride BF, Kluger J. The impact of elevations in catecholamine concentrations on defibrillation threshold in patients with implanted cardioverter-defibrillators. Pacing and Clinical Electrophysiology. 2005; 28: 1147-56 Min B, Kluger J, Kalus JS, Guertin D, McBride BF, White CM. The impact of catecholamines in patients with or without beta-blockers on the ventricular fibrillation cycle length and ventricular fibrillation cycle length variability. Annals of Noninvasive Electrocardiology. 2005; 10: 305-11
|
